Accelerating Telehealth Adoption: Telemedicine’s Role in the Volume to Value Journey

November 16, 2018

There is growing evidence that telehealth expands access to care, improves health outcomes and healthcare quality, increases patient engagement, and reduces healthcare costs. Yet skeptics are concerned about increased utilization and lack of ROI. This URAC Industry Insight Report offers perspectives from leaders on the front lines of telehealth, who are witnessing the risks and rewards as telehealth adoption accelerates rapidly with the transition from volume to value.

Spotlight

Canvax Biotech

For 16 years, Canvax has been an original manufacturer and supplier of the most innovative solutions, services, kits and R&D Reagents inside the Molecular Biology field. Thanks to our reliable, cost-effective and easy-to-use products, we enable our worldwide customers to improve its laboratory productivity and accelerate their discoveries.Based in Córdoba (Spain), since its foundation Canvax has focused on R&D of multiplex high throughput platforms (HTS) for Drug discovery and Diagnostic applied biosensors. Over a decade later, Canvax is a worldwide leading expert in Molecular Biology and GPCR expression in heterologous cells, with important patents and exclusive know-how.

OTHER WHITEPAPERS
news image

Synthetic Biology Biotechnology & AgTech

whitePaper | June 8, 2022

For nearly two decades, the Future Today Institute has meticulously researched macro forces of change and the emerging trends that result. Our focus: understanding how these forces and trends will shape our futures.

Read More
news image

Validation of ICON™ Automated Cell Counting and Viability Assay

whitePaper | August 10, 2022

Determination of cell viability and concentration using trypan blue exclusion is essential for biotherapeutic workflows, enabling optimisation of protocols, monitoring of changes to the culture environment, and selection of the best clones for culture progression.

Read More
news image

Gene, Cell, & RNA Therapy Landscape

whitePaper | January 24, 2022

The American Society of Gene & Cell Therapy (ASGCT) is the primary professional membership organization.

Read More
news image

BIOTECHNOLOGY UPDATE

whitePaper | April 24, 2022

The Global Forum on Biotechnology, established in 2010, is one of 15 Global Fora created by OECD Committees. Global Fora are not official OECD bodiesbut are best described as broad.

Read More
news image

Advancing Diversity in Clinical Development through Cross-Stakeholder Commitment and Action

whitePaper | November 10, 2022

The call for achieving representative diversity in clinical trials and development programs is not new and indeed dates back more than five decades in the United States but has been amplified over the course of the COVID-19

Read More
news image

Best Practices for RIM Business Process Automation

whitePaper | December 15, 2022

Regulatory teams at life science companies are finding that effective regulatory information management (RIM) has become critical to their operations.

Read More

Spotlight

Canvax Biotech

For 16 years, Canvax has been an original manufacturer and supplier of the most innovative solutions, services, kits and R&D Reagents inside the Molecular Biology field. Thanks to our reliable, cost-effective and easy-to-use products, we enable our worldwide customers to improve its laboratory productivity and accelerate their discoveries.Based in Córdoba (Spain), since its foundation Canvax has focused on R&D of multiplex high throughput platforms (HTS) for Drug discovery and Diagnostic applied biosensors. Over a decade later, Canvax is a worldwide leading expert in Molecular Biology and GPCR expression in heterologous cells, with important patents and exclusive know-how.

Events